SENSEX NIFTY
Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

US Court Denies Ranbaxy's Bid to Block Launch of Rival Generics

Nov 20, 2014 at 22:00 | Source: NDTV Profit

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral, a court filing showed. Ranbaxy had filed a lawsuit again...

Ranbaxy to Exit Nifty Junior Index From November 28

Nov 19, 2014 at 02:00 | Source: NDTV Profit

Mumbai: Drug maker Ranbaxy Laboratories is being moved out of the National Stock Exchange's CNX Nifty Junior index and would be replaced by Reliance Infrastructure. The changes have been made on "account of proposed scheme of amalgam...

Ranbaxy sues US drug regulator over revoking approvals

Nov 18, 2014 at 20:00 | Source: VC Circle

Early this month FDA revoked tentative approval to Ranbaxy for selling low-cost versions of Nexium and Valcyte. Daiichi Sankyo-controlled Ranbaxy Laboratories has sued the US Federal Drug Authority (FDA) for revoking approvals granted to it to launch...

USFDA revokes Ranbaxy&#39;s approval to sell generic versions of Nexium and <b>...</b>

Nov 07, 2014 at 16:00 | Source: VC Circle

The American drug regulator has revoked Ranbaxy Laboratories&#39; tentative approval for selling copy cat low cost versions of blockbuster heartburn drug Nexium and anti-viral drug Valcyte in the world&#39;s largest drug market. USFDA said it...

Double blow to Ranbaxy

Nov 07, 2014 at 12:42 | Source: Calcutta Telegraph News

Mumbai, Nov. 6: The US health regulator has revoked tentative approvals to Ranbaxy Laboratories to make the generic versions of AstraZeneca’s heartburn drug Nexium and Roche Holding’s anti-viral Valcyte. The tentative approvals to the tw...

Ranbaxy Shares Fall 5% on US FDA Blow

Nov 07, 2014 at 10:00 | Source: NDTV Profit

Shares in Ranbaxy fell over 5 per cent to a day low of Rs 618.85 in the opening session on Friday after the US Food and Drug Administration (FDA) revoked a tentative approval for Ranbaxy Laboratories two drugs. The US FDA has withdrawn its approval f...

US Pulls Approval for Ranbaxy Copies of AstraZeneca, Roche Drugs

Nov 06, 2014 at 19:59 | Source: NDTV Profit

Mumbai: The US Food and Drug Administration (FDA) has revoked a tentative approval for Ranbaxy Laboratories to make a cheap copy of AstraZeneca&#39;s heartburn drug Nexium, after its Indian plants were banned over quality control issues. The FDA ...

Ranbaxy Loses Six Months Exclusivity on Roche&#39;s Antiviral Drug

Nov 06, 2014 at 18:00 | Source: NDTV Profit

Mumbai: Drug maker Ranbaxy Laboratories Ltd said the US Food and Drug Administration (FDA) has revoked the previously granted tentative approvals to the company for launching the first cheaper generic forms of AstraZeneca&#39;s heartburn drug Nex...

US boost for Ranbaxy net

Oct 29, 2014 at 03:42 | Source: Calcutta Telegraph News

Mumbai, Oct. 28: Ranbaxy Laboratories today reported its first net profit in six quarters, gaining from the exclusive US launch of a cheaper copy of Novartis�s blood pressure pill Diovan. The drug firm, which is being bought by larger rival Sun Ph...

Ranbaxy Still Has Exclusive Rights for Nexium Generic: CEO

Oct 28, 2014 at 22:00 | Source: NDTV Profit

Mumbai: Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca&#39;s heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process. Ranbaxy was the first to seek ap...

Nifty Climbs to 1-Month Closing High; Ranbaxy Up After Profit

Oct 28, 2014 at 20:00 | Source: NDTV Profit

Mumbai: The BSE Sensex and Nifty rose on Tuesday to their highest close in more than a month, with drugmakers getting a shot in the arm after Ranbaxy Laboratories Ltd reported its first profit in six quarters. Lenders also extended recent gains on ...

Sensex Rises 127 Points to End at Over 1-Month High

Oct 28, 2014 at 20:00 | Source: NDTV Profit

The BSE Sensex and Nifty rose on Tuesday to their highest close in more than a month, with drugmakers getting a boost after Ranbaxy Laboratories reported its first profit in six quarters. Lenders also extended recent gains on rising expectations the ...

Ranbaxy Falls on Buzz of Losing Nexium Exclusivity Period

Oct 27, 2014 at 12:00 | Source: NDTV Profit

Shares in Ranbaxy Laboratories fell over one per cent to a day low of Rs 589 on Monday as reports suggest that the company may lose six-month of exclusivity period for the generic version of Nexium, if it fails to get regulatory clearances for the US...

Cadila recalls drug in US

Oct 18, 2014 at 20:22 | Source: Calcutta Telegraph News

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was volu...

Ranbaxy buys Texas peace

Oct 17, 2014 at 12:32 | Source: Calcutta Telegraph News

Mumbai, Oct. 16: Ranbaxy Laboratories today said it would pay $39.75 million (Rs 244 crore) to the state of Texas in the US to settle the litigation with regard to its participation in a social health scheme meant for the poor. “The company ha...

No CCI Directive to Sell Business For Merger Nod with Sun Pharma: Ranbaxy

Oct 16, 2014 at 23:59 | Source: NDTV Profit

New Delhi: Ranbaxy Laboratories, which is in the process of a $4 billion merger with Sun Pharma, said on Thursday the two firms as on date have not received any direction from the CCI to sell parts of their businesses as a pre-condition to approve th...

Ranbaxy to Pay $40 Million to Settle Texas Litigation

Oct 16, 2014 at 14:00 | Source: NDTV Profit

Mumbai: Generic drugmaker Ranbaxy Laboratories Ltd said it has agreed to pay $39.75 million to settle litigation concerning its participation in Texas Medicaid, the US federal-state healthcare program for people with low incomes. The litigation relat...

Ranbaxy Launches Acne Treatment Capsules in US

Oct 01, 2014 at 22:00 | Source: NDTV Profit

New Delhi: Drug firm Ranbaxy Laboratories on Wednesday launched a capsule used for treatment of severe acne in the US. Ranbaxy Laboratories Inc, a subsidiary of the company, has announced the launch of Absorica capsules in the strengths of 25 mg&...

Strides, Shasun pop merger pill

Sep 30, 2014 at 12:57 | Source: Calcutta Telegraph News

Mumbai, Sept: 29: Chennai-based Shasun Pharmaceuticals Ltd will be merged with generic drug maker Strides Arcolab to create a Rs 2,500-crore entity spanning across multiple segments. The merged entity will figure among the top 15 listed Indian pharm...

Corporate India s legal costs increase 17.5% in 2013-14

Sep 27, 2014 at 13:17 | Source: Economic Times

MUMBAI: An overhead cost is steadily expanding for Indian companies as they aggressively push in overseas markets and regulations become tougher at home and abroad. More than 1,800 listed companies that the ET Intelligence Group has analysed have col...

video of the day

Rupee weakness modest, see yields at 7.60% in Q1: Deutsche

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.